Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BAX Baxter International	$30.03 +0.8%	$30.31	$26.25 ▼ $40.49	$15.29B	0.61	4.41 million shs	5.60 million shs
HOLX Hologic	$64.48 +0.8%	$59.29	$51.90 ▼ $84.67	$14.26B	0.55	2.35 million shs	5.56 million shs
MASI Masimo	$165.18 +1.5%	$158.88	$101.61 ▼ $194.88	$8.83B	1.19	640,601 shs	630,756 shs
WMGI Wright Medical Group	$29.98	$30.23	$23.14 ▼ $30.74	$3.90B	0.57	2.02 million shs	9,689 shs

The Best Nuclear Energy Stocks to Buy

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BAX Baxter International	+0.67%	-1.88%	-1.31%	-9.60%	-10.98%
HOLX Hologic	+0.80%	-0.42%	+17.62%	+4.90%	-9.78%
MASI Masimo	+1.48%	+2.47%	+10.57%	-0.39%	+21.63%
WMGI Wright Medical Group	0.00%	0.00%	0.00%	0.00%	0.00%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BAX Baxter International	4.4283 of 5 stars	2.2	3.0	1.7	4.0	2.8	1.7	2.5
HOLX Hologic	4.7178 of 5 stars	3.2	5.0	0.0	4.3	2.9	3.3	1.3
MASI Masimo	4.0569 of 5 stars	3.4	1.0	0.0	4.2	1.8	2.5	1.3
WMGI Wright Medical Group	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BAX Baxter International	2.44	Hold	$37.25	24.06% Upside
HOLX Hologic	2.41	Hold	$77.42	20.06% Upside
MASI Masimo	2.83	Moderate Buy	$191.60	15.99% Upside
WMGI Wright Medical Group	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest WMGI, BAX, HOLX, and MASI Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/27/2025	HOLX Hologic	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold
5/13/2025	HOLX Hologic	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$77.00 ➝ $70.00
5/7/2025	MASI Masimo	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy ➝ Buy	$193.00
5/7/2025	MASI Masimo	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$215.00 ➝ $200.00
5/7/2025	MASI Masimo	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$204.00 ➝ $185.00
5/7/2025	MASI Masimo	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$205.00 ➝ $190.00
5/5/2025	BAX Baxter International	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Underweight ➝ Underweight	$30.00 ➝ $28.00
5/5/2025	HOLX Hologic	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$77.00 ➝ $65.00
5/2/2025	BAX Baxter International	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$36.00 ➝ $33.00
5/2/2025	HOLX Hologic	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Sector Perform ➝ Sector Perform	$75.00 ➝ $70.00
5/2/2025	HOLX Hologic	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$90.00 ➝ $71.00

(Data available from 6/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BAX Baxter International	$10.77B	1.43	$4.79 per share	6.27	$13.76 per share	2.18
HOLX Hologic	$4.03B	3.57	$5.54 per share	11.63	$22.09 per share	2.92
MASI Masimo	$2.13B	4.21	$6.48 per share	25.48	$19.50 per share	8.47
WMGI Wright Medical Group	$920.90M	4.23	$1.23 per share	24.31	$7.03 per share	4.26

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BAX Baxter International	-$649M	-$1.10	N/A	11.00	0.88	-4.71%	17.24%	5.12%	8/5/2025 (Estimated)
HOLX Hologic	$789.50M	$2.37	27.21	13.96	2.34	13.83%	19.71%	10.87%	8/4/2025 (Estimated)
MASI Masimo	-$304.90M	-$9.17	N/A	35.68	N/A	-25.06%	22.56%	10.00%	8/5/2025 (Estimated)
WMGI Wright Medical Group	-$114.22M	$0.06	N/A	47.59	6.37	-16.59%	-3.86%	-1.32%	N/A

Latest WMGI, BAX, HOLX, and MASI Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/6/2025	Q1 2025	MASI Masimo	$1.24	$1.36	+$0.12	-$3.12	$367.79 million	$372.00 million
5/1/2025	Q1 2025	BAX Baxter International	$0.48	$0.62	+$0.14	$0.25	$2.59 billion	$2.63 billion
5/1/2025	Q2 2025	HOLX Hologic	$1.02	$1.03	+$0.01	-$0.08	$1.00 billion	$1.01 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BAX Baxter International	$0.68	2.26%	N/A	N/A	N/A
HOLX Hologic	N/A	N/A	N/A	N/A	N/A
MASI Masimo	N/A	N/A	N/A	N/A	N/A
WMGI Wright Medical Group	N/A	N/A	N/A	N/A	N/A

Latest WMGI, BAX, HOLX, and MASI Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/6/2025	BAX Baxter International	quarterly	$0.17	2.27%	5/30/2025	5/30/2025	7/1/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BAX Baxter International	1.33	2.02	1.40
HOLX Hologic	0.54	3.24	2.52
MASI Masimo	0.67	2.17	1.62
WMGI Wright Medical Group	0.90	0.82	0.54

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BAX Baxter International	90.19%
HOLX Hologic	94.73%
MASI Masimo	85.96%
WMGI Wright Medical Group	N/A

Insider Ownership

Company	Insider Ownership
BAX Baxter International	0.21%
HOLX Hologic	1.88%
MASI Masimo	9.70%
WMGI Wright Medical Group	4.10%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BAX Baxter International	38,000	513.18 million	512.10 million	Optionable
HOLX Hologic	7,063	222.85 million	218.66 million	Optionable
MASI Masimo	5,600	54.22 million	48.96 million	Optionable
WMGI Wright Medical Group	3,030	129.94 million	N/A	Optionable

WMGI, BAX, HOLX, and MASI Headlines

Recent News About These Companies

Outset Medical Appoints Kevin O’Boyle to Board of Directors and Audit Committee Chair

May 14, 2025 | quiverquant.com

Wright named chief clinical integration officer at State of Franklin

October 31, 2024 | heraldcourier.com

Jarah Wright

October 31, 2024 | ktnv.com

‘What we signed up for.’ Wright-Patt’s sole flying mission ready to defend in peacetime and war

October 18, 2024 | daytondailynews.com

Vanderbilt forward Kijani Wright out indefinitely with health issue

October 9, 2024 | msn.com

Vanderbilt basketball's Kijani Wright out indefinitely with medical condition

October 9, 2024 | sports.yahoo.com

Fallingwater: Exterior and Interior

October 4, 2024 | pbs.org

General Hospital’s Laura Wright Suffers a Mishap That ‘Did Look a Little Spooky,’ Co-Star Admits

September 26, 2024 | msn.com

This Green Bay mental health group is helping men throughout the community by talking about their week

September 26, 2024 | msn.com

The Wright Medicine: Women encouraged to prioritize health and fitness goals

September 19, 2024 | thevalleyadvantage.com

Wright County Seeks Community Input for Health Policy Enhancement Through New Survey Initiative

September 15, 2024 | hoodline.com

WrightLife Insurance Group Provides Alternative Affordable Healthcare Options with Concierge Level of Service

September 13, 2024 | markets.businessinsider.com

General Hospital’s Laura Wright Dishes On Willow’s Affair: ‘What The Hell, Drew?’

September 11, 2024 | yahoo.com

Wright Center highlights hunger awareness

September 2, 2024 | timesleader.com

Wright State Physicians CEO shares advice to her 'younger self'

August 25, 2024 | bizjournals.com

Wright Lassiter: $100M Morehouse School of Medicine partnership transcends hospital limits

August 22, 2024 | beckershospitalreview.com

Two new trustees appointed to Wright State board

August 12, 2024 | yahoo.com

End of watch: Community mourns loss of K-9 officer Wright

August 9, 2024 | grahamleader.com

(Exclusive) Wright State and Premier Health proceed on unique partnership

July 23, 2024 | bizjournals.com

Jason Wright is out as Washington Commanders president and will leave the team after the ’24 season

July 19, 2024 | wgntv.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

WMGI, BAX, HOLX, and MASI Company Descriptions

Baxter International NYSE:BAX

$30.02 +0.23 (+0.76%)

Closing price 06/20/2025 03:59 PM Eastern

Extended Trading

$30.03 +0.01 (+0.02%)

As of 06/20/2025 06:05 PM Eastern

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Hologic NASDAQ:HOLX

$64.48 +0.51 (+0.80%)

Closing price 06/20/2025 04:00 PM Eastern

Extended Trading

$64.70 +0.22 (+0.34%)

As of 06/20/2025 06:59 PM Eastern

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and connectivity solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, the company offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Masimo NASDAQ:MASI

$165.18 +2.41 (+1.48%)

Closing price 06/20/2025 04:00 PM Eastern

Extended Trading

$165.22 +0.03 (+0.02%)

As of 06/20/2025 06:13 PM Eastern

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.

Wright Medical Group NASDAQ:WMGI

Wright Medical Group N.V., a medical device company, designs, manufactures, markets, and sells upper and lower extremities, and biologics products in the United States, Europe, the Middle East, Africa, Canada, Asia, Australia, and Latin America. The company offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth. It also provides sports medicines and other products to mechanically repair tissue-to-tissue or tissue-to-bone injuries, as well as other ancillary products. The company offers its products to orthopedic, trauma, and podiatric surgeons. It markets and sells its products through direct sales representatives, independent sales agencies, direct sales offices, and distributors. The company was founded in 1999 and is headquartered in Amsterdam, the Netherlands.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time